Medicare announced Thursday it will cover Dendreon’s prostate cancer drug Provenge, which has been shown to extend life for about four months for patients with late stages of the disease but costs up to $93,000.
Read more from the
Please log in using one of these methods to post your comment:
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.